Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Community-Acquired Bacterial Pneumonia (CABP)”

17 trials

Showing 17 of 17 results

Large-scale testing (Phase 3)Study completedNCT01968733
What this trial is testing

Efficacy and Safety Study of Intravenous to Oral Solithromycin (CEM-101) Compared to Intravenous to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia

Who this might be right for
Community-acquired Bacterial Pneumonia
Melinta Therapeutics, Inc. 863
Large-scale testing (Phase 3)Study completedNCT04779242
What this trial is testing

Omadacycline vs. Moxifloxacin for the Treatment of Community-Acquired Bacterial Pneumonia

Who this might be right for
Community-acquired PneumoniaBacterial Pneumonia
Paratek Pharmaceuticals Inc 670
Testing effectiveness (Phase 2)Ended earlyNCT01198626
What this trial is testing

Efficacy and Safety Study of JNJ-32729463 Compared With Moxifloxacin for the Treatment of Subjects Requiring Hospitalization for Community-Acquired Bacterial Pneumonia

Who this might be right for
Community-Acquired Bacterial Pneumonia (CABP)
Furiex Pharmaceuticals, Inc 32
Large-scale testing (Phase 3)Study completedNCT01530763
What this trial is testing

Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Community Acquired Bacterial Pneumonia (CABP)

Who this might be right for
InfectionsCommunity Acquired Pneumonia
Forest Laboratories 161
Large-scale testing (Phase 3)Study completedNCT01605864
What this trial is testing

Use of Ceftaroline in Hospitalized Patients With Community Acquired Pneumonia

Who this might be right for
Community Acquired Bacterial Pneumonia
Albany Medical College 12
Large-scale testing (Phase 3)Study completedNCT02531438
What this trial is testing

Omadacycline vs Moxifloxacin for the Treatment of CABP (EudraCT #2013-004071-13)

Who this might be right for
Bacterial PneumoniaCommunity-Acquired Infections
Paratek Pharmaceuticals Inc 774
Large-scale testing (Phase 3)Study completedNCT02559310
What this trial is testing

Study to Compare Lefamulin to Moxifloxacin (With or Without Linezolid) for the Treatment of Adults With Pneumonia

Who this might be right for
Community Acquired Pneumonia
Nabriva Therapeutics AG 551
Post-approval studies (Phase 4)Study completedNCT01524302
What this trial is testing

Pharmacodynamic of Ceftaroline and Levofloxacin Against Pathogens Associated With Community Acquired Bacterial Pneumonia

Who this might be right for
Pneumonia, BacterialCommunity-acquired
Gary E. Stein, Pharm.D. 12
Post-approval studies (Phase 4)Looking for participantsNCT06804096
What this trial is testing

Efficacy and Safety of Faropenem in Bangladeshi Adult Patients With Community-Acquired Bacterial Pneumonia (CABP)

Who this might be right for
Pneumonia, Community-AcquiredBacterial Pneumonia
Dr. Md. Alimur Reza 160
Post-approval studies (Phase 4)Study completedNCT01669980
What this trial is testing

Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Community Acquired Pneumonia (CABP)

Who this might be right for
InfectionsPneumonia
Forest Laboratories 40
Large-scale testing (Phase 3)Looking for participantsNCT06162286
What this trial is testing

A Phase 3b Randomized, Double-blind, Multi-center Study to Compare the Safety and Efficacy of Omadacycline to Moxifloxacin for Treating Adult Subjects With CABP

Who this might be right for
Community-acquired Bacterial Pneumonia
Zai Lab (Hong Kong), Ltd. 100
Large-scale testing (Phase 3)Study completedNCT02813694
What this trial is testing

Study to Compare Lefamulin to Moxifloxacin for the Treatment of Adults With Pneumonia

Who this might be right for
Community Acquired Pneumonia
Nabriva Therapeutics AG 738
Testing effectiveness (Phase 2)Study completedNCT02903836
What this trial is testing

Phase II Study of Oral Nafithromycin in CABP

Who this might be right for
Community-Acquired Bacterial Pneumonia (CABP)
Wockhardt 231
Post-approval studies (Phase 4)Study completedNCT01645735
What this trial is testing

Evaluation of Ceftaroline Fosamil Versus a Comparator in Adult Subjects With Community-acquired Bacterial Pneumonia (CABP) With Risk for Methicillin-resistant Staphylococcus Aureus

Who this might be right for
Infections
Forest Laboratories 49
Large-scale testing (Phase 3)Study completedNCT01756339
What this trial is testing

Efficacy and Safety Study of Oral Solithromycin (CEM-101) Compared to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia

Who this might be right for
Community-acquired Bacterial Pneumonia
Melinta Therapeutics, Inc. 860
Post-approval studies (Phase 4)WithdrawnNCT01666743
What this trial is testing

Safety and Efficacy Study of Ceftaroline in Elderly Subjects With Community-Acquired Bacterial Pneumonia

Who this might be right for
Community-Acquired Bacterial Pneumonia (CABP)
Forest Laboratories
Early research (Phase 1)Study completedNCT04160260
What this trial is testing

Study to Evaluate the PK of PO Omadacycline in Adults With Community-Acquired Bacterial Pneumonia

Who this might be right for
Community-acquired Pneumonia
Paratek Pharmaceuticals Inc 18

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation